A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis
Condition:   Progressive Multiple SclerosisInterventions:   Drug: Acyclovir;   Drug: Methylprednisolone;   Drug: alemtuzumab GZ402673;   Drug: alemtuzumab GZ402673;   Drug: Paracetamol;   Drug: Loratadine;   Drug: Ceterizine;   Drug: DexchlorpheniramineSponsor:   Genzyme, a Sanofi CompanyNot yet recruiting - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2015 Category: Research Source Type: clinical trials

Bioequivalence of Topical Acyclovir in Healthy Volunteers
Condition:   Dermatologic DisordersInterventions:   Drug: 5% Zovirax® cream;   Drug: 5% Aciclostad cream;   Drug: 5% Aciclovir cream 1A Pharma;   Drug: 5% Zovirax Cold Sore Cream;   Drug: 5% Zovirax® cream (Austria);   Procedure: OFM;   Device: OFM Probe;   Device: OFM PumpSponsors:   Medical University of Graz;   JOANNEUM RESEARCH Forschungsgesellschaft mbHCompleted - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2015 Category: Research Source Type: clinical trials